Regeneron Pharmaceuticals

Photo

Regeneron Invests $1.8 Billion in Tarrytown

US biotech Regeneron is planning to invest roughly $1.8 billion over six years to expand its research, preclinical manufacturing and support facilities at its Westchester County campus in Tarrytown, New York.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.